QA: Kiora Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001372514_2021_Kiora_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001372514, Kiora Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 1,810,149
1 IntangibleAssetsNetIncludingGoodwill 13,214,771
2 PropertyPlantAndEquipmentNet 30,566
3 remainder_Assets 102,073
4 LiabilitiesCurrent 1,772,327
5 LiabilitiesNoncurrent 6,385,691
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,743,417
9 ResearchAndDevelopmentExpense 1,661,558
10 remainder_Expenses 14,559
11 remainder_Revenues 2,677,234
12 remainder_NetIncome 124,235
13 remainder_ComprehensiveNetIncome -90,639
  yvar yval
0 Assets 15,157,559
1 Liabilities 8,158,018
2 Expenses 6,419,534
3 Revenues 2,677,234
4 StockholdersEquity 6,999,541
5 NetIncome -3,618,065
6 ComprehensiveNetIncome -3,663,384
7 BaseVar 16,313,610
8 EconomicCapitalRatiobeforeLimitedLiability 0.995
9 EconomicCapitalRatio 2.30

Edgar->Model Mapping

Feature Distribution

Change over Time